Evidence synthesis and guideline development in genomic medicine: current status and future prospects - Wikidata - wikimedia - TriplyDB

Evidence synthesis and guideline development in genomic medicine: current status and future prospects

Evidence synthesis and guideline development in genomic medicine: current status and future prospects

http://www.wikidata.org/entity/Q27010101

about

Stakeholder engagement in policy development: challenges and opportunities for human genomics Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research Assessing the readiness of precision medicine interoperabilty: An exploratory study of the National Institutes of Health genetic testing registry.Application of the GRADE Approach in the Development of Guidelines and Recommendations in Genomic Medicine.From public health genomics to precision public health: a 20-year journey.Precision medicine in diabetes prevention, classification and management.

P2860

Q28607745-C0B8650F-6E4E-4976-80F5-4F6C1048C2C3 Q35679753-9C888008-422B-41CE-B830-01035E22D9CE Q38248763-4F5A07FB-40CF-4ACD-93EC-6144B63AF762 Q38730837-FEFA9CCB-6C83-4D80-B556-DCAB7149EBD6 Q48503018-34101681-31BD-440B-A39B-A15C76DC3A5A Q49610657-C84A2FA0-B803-48B9-B97E-EBDB7CACC163 Q49841808-89A62A21-BE4F-40FC-AF6D-43469CF1DF2F Q52677048-51D91915-6606-4CCD-8D6A-73EA3BDAA0E4

P2860

Evidence synthesis and guideline development in genomic medicine: current status and future prospects

http://www.wikidata.org/entity/Q27010101

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Evidence synthesis and guideli ...... nt status and future prospects

@ast

Evidence synthesis and guideli ...... nt status and future prospects

@en

Evidence synthesis and guideli ...... nt status and future prospects

@nl

type

label

Evidence synthesis and guideli ...... nt status and future prospects

@ast

Evidence synthesis and guideli ...... nt status and future prospects

@en

Evidence synthesis and guideli ...... nt status and future prospects

@nl

prefLabel

Evidence synthesis and guideli ...... nt status and future prospects

@ast

Evidence synthesis and guideli ...... nt status and future prospects

@en

Evidence synthesis and guideli ...... nt status and future prospects

@nl

P1433

Q27010101-21D6CBA8-70B9-4C8A-B8DC-D3D609CA85A5

P1476

Q27010101-82C24540-86E9-4DC2-B59E-57C3DF70BFAD

P2093

Q27010101-096D7067-818B-49D4-AA37-4F2E32D31DE8

Q27010101-16E77B35-2B85-4AD8-A663-3C77826DD9DF

Q27010101-1B7B65B6-3741-438A-8BBC-715C5AE172EF

Q27010101-1FC60B38-249E-4C62-BE18-012FB71AC384

Q27010101-2E3BF722-7E60-4A76-A81F-CE6EB981550D

Q27010101-2FF34D74-B1E2-43E9-9B98-CEA7A9579309

Q27010101-3045B387-5848-4AC5-955E-DDD27C352859

Q27010101-35433B0E-321B-4269-B20F-F6A013FBD291

Q27010101-3DB47B5B-2C70-4EEB-B463-514B4FA1CB75

Q27010101-5E2970F4-3791-48C5-A2D9-83914280218B

P2860

Q27010101-20FC5071-EF98-4AF2-8C9E-C61CAB7D1437

Q27010101-2B7A606E-9276-451B-831F-83320F1512D2

Q27010101-3F4390A4-D4BC-4C39-BE90-2F9DF781AC04

Q27010101-4FB9132B-7115-4961-9266-32F0159505D1

Q27010101-5DB1C53C-BEF5-4A49-91CB-5376EC31F9F5

Q27010101-5F81126E-ABBA-4DA0-B258-A17A14FA658A

Q27010101-709011C0-2F61-4F02-A937-CEF4F68BF6CD

Q27010101-7DF5A666-6E2A-4D87-8D8B-DF2D334C9846

Q27010101-8EEACF3C-D226-4B6E-93D0-D9072C362EEA

Q27010101-978B90CE-079D-4522-AF8B-A9359DC81200

P2888

Q27010101-49325AB1-28F5-4DC0-875A-D44FBB006006

P304

Q27010101-B5D28E32-1590-48D9-82DD-7A202CFFB309

P31

Q27010101-517D166C-9439-4BDA-8DBB-2E28314AC318

P356

Q27010101-E137A21F-2563-4B46-9DF4-29518DCB2DD1

P407

Q27010101-AC1AD03B-C7F5-4AFB-8241-6A8503D43FB1

P433

Q27010101-23759AA9-E62C-40BA-82E1-C1AA7629C5F1

P478

Q27010101-E2A5BE0D-DF83-4A96-BF33-0B2F262EE6A7

P50

Q27010101-74202307-71DF-42E7-A76B-187ADD893381

Q27010101-9F0FDB64-7AF2-446B-836D-A637AB12EE7B

Q27010101-AF6B264D-2A58-434B-B604-AD7A3A5F74A2

Q27010101-E48CD058-BF0A-4196-A821-6943BD038602

P577

Q27010101-F036A74A-B2A1-4448-B988-36AFE019988F

P5875

Q27010101-37A9AF68-44D7-46C5-8619-1B2503811095

P6179

Q27010101-77F87A32-76EB-4759-8EBC-8FCAD96AFBB8

P698

Q27010101-1C94A8A5-2A81-4340-8032-FE0105C4F44F

P932

Q27010101-4FBD1D19-90C1-46DF-A9E5-B749FA6AE51F

P356

P1433

Genetics in Medicine

P1476

Evidence synthesis and guideli ...... nt status and future prospects

@en

P2093

Adam H. Buchanan

http://www.w3.org/2001/XMLSchema#string

Christina G.S. Palmer

http://www.w3.org/2001/XMLSchema#string

Christine Q. Chang

http://www.w3.org/2001/XMLSchema#string

Gary H. Lyman

http://www.w3.org/2001/XMLSchema#string

Jesse J. Swen

http://www.w3.org/2001/XMLSchema#string

Joseph Lau

http://www.w3.org/2001/XMLSchema#string

Kathleen Calzone

http://www.w3.org/2001/XMLSchema#string

Katrina A.B. Goddard

http://www.w3.org/2001/XMLSchema#string

Marc S. Williams

http://www.w3.org/2001/XMLSchema#string

Marian L. Birkeland

http://www.w3.org/2001/XMLSchema#string

P2860

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Pharmacogenomics knowledge for personalized medicine

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Characterizing genetic variants for clinical action

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Horizon scanning for translational genomic research beyond bench to bedside.

Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.

Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas.

Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing.

P2888

P304

63-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2014.69

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Djulbegovic

Sheri D Schully

Sharon F. Terry

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263297533

http://www.w3.org/2001/XMLSchema#string

P6179

1000366273

http://www.w3.org/2001/XMLSchema#string

P698

24946156

http://www.w3.org/2001/XMLSchema#string

P932

4272332

http://www.w3.org/2001/XMLSchema#string